Evelina Lokshina

Dr. Evelina Lokshina


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2020 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
ELEvelina Lokshina
Evelina Lokshina
OZO. V. Zaytseva
O. V. Zaytseva
SZS. V. Zaytseva
S. V. Zaytseva
Fever in children is one of the most common reasons for seeking medical care and use of antipyretic drugs. The reasons can be various. It is extremely important for the pediatrician to find the cause of the fever and prescribe adequate therapy. Antipyretic drugs are symptomatic, they only relieve the condition of the child and improve the quality of life. The article reviews national and international studies and clinical guidelines of professional communities on fever in children. Currently, only ibuprofen and paracetamol fully meet the safety and efficacy criteria, and they are recommended for use in pediatric practice as antipyretic drugs.

12 March 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
EIE. P. Isaeva
E. P. Isaeva
OZO. V. Zaytseva
O. V. Zaytseva
ELEvelina Lokshina
Evelina Lokshina
OMO. A. Murtazaeva
O. A. Murtazaeva
SZS. V. Zaytseva
S. V. Zaytseva
IZI. V. Zyabkin
I. V. Zyabkin
Introduction. After an infection with the SARS-CoV-2 virus, in some cases, the so-called post-covid syndrome is formed, which includes conditions and symptoms that develop during and / or after the disease, lasting more than 12 weeks, occurring in waves or on a permanent basis, and without a confirmed alternative diagnosis. Vegetative, psycho-emotional disorders, as well as disorders of the cardiovascular system, digestive and some others can be considered as manifestations of the post-covid syndrome. The variety of clinical manifestations of post-COVID syndrome in children can have a significant impact on their quality of life (QoL).Aim. To estimate the quality of life of children aged 5 to 17 years after COVID-19.Materials and methods. The study included 92 children aged 5 to 17 years, divided into two groups. The study group included 62 children (31 boys, 31 girls; mean age 12.0 (7.4; 14.5) years) after a new coronavirus infection. The control group consisted of 30 children who had acute respiratory tract infection of a different etiology and did not have COVID-19 (16 girls and 14 boys; mean age 12.5 (7.5; 15.1) years). The assessment of QoL in children of the study groups was carried out using the Russian version of the PedsQL 4.0 questionnaire. Parental and child forms of the questionnaire were used.Results. The average follow-up period after a coronavirus infection was 6 months (from 3 to 12 months). 92 patient questionnaires were analyzed: 14 in the group of children 5–7 years old, 36 in the group of children 8–12 years old, 42 in the group of children and adolescents 13–17 years old, and 14 parental questionnaires in the group of children 5–7 years old. The indicators of the quality of life of children after COVID-19 were statistically significantly reduced compared to the control group in all age groups. Differences in the assessment of the quality of life by preschool children and their parents were revealed.Conclusions. A significant decrease in the life quality was revealed in children with COVID-19 history after six months (3–12 months) of the disease manifestation in comparison with control group.

8 June 2024 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
STSofya A. Tsarkova
Sofya A. Tsarkova
OZOlga V. Zaytseva
Olga V. Zaytseva
ELEvelina Lokshina
Evelina Lokshina
SZSvetlana V. Zaytseva
Svetlana V. Zaytseva
EIElena P. Isaeva
Elena P. Isaeva
ХЮХалидуллина Оксана Юрьевна
Халидуллина Оксана Юрьевна
Background. Currently, there are no multicenter studies to determine the prevalence and incidence of symptoms of post-COVID syndrome (PCS) in children in different age groups, to develop consistent observation algorithms, and to identify therapy options. Aim. To establish the risk factors for PCS in children and its CSs in the Russian Federation. Materials and methods. A retrospective multicenter cross-sectional study was conducted. The initial stage of the study included 565 children at 7.6±0.17 months after the new coronavirus infection (NCVI) who were on outpatient or inpatient observation in different regions of Russia from November 2022 to May 2023. Patients were selected from 9 regions of the Russian Federation, such as Izhevsk, Kemerovo, Moscow, Omsk and Omsk region, Yekaterinburg and Sverdlovsk region, Ufa, Tyumen, Samara, Naberezhnye Chelny. All patients were offered a questionnaire. The questionnaire was developed and adapted based on the British and American consensus on the PCS, which included an assessment of the history, severity of the disease, clinical form of acute NCVI, therapy in the acute period of NCVI, and the presence of comorbidities. In addition, the course of acute NCVI and symptoms 3 months after the disease were evaluated by the following groups of CS: asthenia, respiratory disorders (RD), gastrointestinal disorders (GI), neurocognitive disorders (NCD), skin/adnexal lesions, olfactory/taste disorders, autonomic dysfunction (AD), anxiety. Of the 565 questionnaires received, 435 (76.9%) met the inclusion criteria and were available for subsequent analysis. The mean age was 9.0±0.25 years. Results. During the acute period of the NCVI, asthenic syndrome (AS), RD and NCD, anxiety symptoms, olfactory/taste disorders, manifestations of AD, GI and skin/adnexal lesions were most often detected. Our study showed that after 3 months or more after NKVI, AS, NCD, and RD recurred in almost half of the observed children (53.1, 49.0 and 47.8%, respectively), anxiety was detected in 42,5% of cases, in more than 1/5 of children, AD, olfactory/taste and gastrointestinal disorders, in 14.3% skin/appendage lesions. Even 90 days after recovery from NCVI, more than half of patients reported impaired functionality, and most children had multiple complaints, which significantly impaired their quality of life. The risk of developing certain manifestations of PCS was increased in patients with comorbidities. Conclusion. The study found that PCS developed in patients with severe, moderate, and mild acute COVID-19. The presence of comorbidities (allergic, neurological diseases, ENT disorders) statistically significantly increased the risk of PCS. The study's results further confirm the importance of continuous monitoring of NKVI sequelae in children and adolescents and the need for follow-up in children recovered from NKVI for 3-12 months.

28 February 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
ELEvelina Lokshina
Evelina Lokshina
OZO. V. Zaytseva
O. V. Zaytseva
Cough is one of the most common symptoms in daily pediatric practice. Clinical presentation of cough in children may vary from a slight cough that has almost no impact on well-being and behaviour, to a strong, painful one that disrupts sleep and overall health status, which significantly worsens the child’s quality of life. Cough is a multidisciplinary problem due to a wide variety of causes, that’s why in the clinical pediatric practice there are certain difficulties in verifying the diagnosis, especially in children with prolonged cough, and in selecting the optimal treatment. The need for mucoactive therapy and the choice of a drug primarily depend on the cause and nature of the cough, the features of the development of the cough reflex in childhood, as well as the mechanisms of action of the drugs used. The main purpose of mucoactive drugs is to restore mucociliary clearance and effectively eliminate secretions from the respiratory tract, but apart from them some drugs have a few additional properties. The article presents the main causes of acute and chronic cough in children and considers the modern therapy options to treat cough. Ambroxol is one of the most commonly used mucoactive drugs to treat cough in children due to its pronounced mucolytic, expectorant, anti-inflammatory, antioxidant and immunomodulatory activity, as well as stimulation of surfactant synthesis. Ambroxol has been shown to have efficacy and favourable safety profile in numerous international and Russian studies. A wide choice of dosage forms, which provide different routes of medication administration, allows to use Ambroxol in children with acute and chronic bronchopulmonary diseases from an early age.

13 March 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
SZS. V. Zaytseva
S. V. Zaytseva
OZO. V. Zaytseva
O. V. Zaytseva
ELEvelina Lokshina
Evelina Lokshina
Acute respiratory infections are leading in the structure of infectious pathology in children. Despite the high importance of viruses in the etiology of acute respiratory infections, the role of bacterial pathogens remains important. Features of the current course, high frequency of complications, unreasonable prescription of antibacterial drugs and the risk of developing drug-resistant forms of microorganisms require adherence to algorithms for the timely diagnosis of bacterial infections and the rational use of antibacterial drugs. In the article, on the example of the analysis of clinical cases, the main stages of diagnosis and algorithms for choosing the initial antibiotic therapy for acute respiratory infections of the upper respiratory tract in children in an outpatient setting are considered. In the first clinical case, the principles of differential diagnosis of viral and bacterial acute otitis media, the risks of adverse outcome are considered, the main indications for prescribing systemic antibiotic therapy in preschoolers are identified. The second clinical case demonstrates the algorithms for diagnosing bacterial sinusitis, the possible masks of the disease, and the selection of a starting antibacterial drug. The example of the third clinical case shows the etiological diversity of acute tonsillopharyngitis in children, defined indications for systemic antibacterial therapy. It has been noted that only streptococcal tonsillopharyngitis is the primary indication of antibacterial prescription. The features of initial therapy and the duration of the course of antibacterial drugs in children were determined.

13 November 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
ELEvelina Lokshina
Evelina Lokshina
TRT. I. Rychkova
T. I. Rychkova
EKE. V. Kulikova
E. V. Kulikova
IOI. P. Ostroukhova
I. P. Ostroukhova
GKG. B. Kuznetsov
G. B. Kuznetsov
The article is dedicated to the issue of acute respiratory infections in children. Acute respiratory infections (ARI) are the most common infectious diseases among both adults and children. The article presents data on the 2020/2021 ARVI and influenza epidemic season in the Russian Federation, which was characterized by an earlier beginning of the rise in the incidence of ARVI and influenza, a wide geographic spread, the highest rates of respiratory infections in children aged 1–2 and 3–6 years, high intensity of the epidemic process, the predominant circulation of influenza A (H3N2) viruses, and the low incidence, absence of severe disease and low mortality among vaccinated against the flu. Modern options for specific prevention of ARI (vaccination against influenza and other infections as part of the national and regional schedules) and non-specific prevention (implementation of the healthy lifestyle principles, including a day regimen, age-adequate nutrition, environmental control, cold exposure training and therapeutic exercise, avoidance of second-hand smoking, vitamin therapy, reduction of potential exposure to sources of infection, use of anti-epidemic measures in the site of infection, regular ventilation and moist mopping, hand washing, elimination therapy, barrier protective devices, use of systemic bacterial lysates, synthetic molecules) are discussed. The principles of rational ARI therapy are provided. The use of essential oil combinations with a composition of oils at certain proportions is one of the promising directions for therapy and prevention of acute respiratory infections. The results of numerous studies assessing the efficacy and safety of the inhalation administration of natural essential oil compositions as part of the combination therapy and prevention of acute respiratory infections in children are provided, good tolerance and high efficacy of essential oil inhalations are observed.